CXM vs REGN · P/E 22, rev $433.2M vs P/E 14, rev $4.29B
Sprinklr Inc (CXM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Sprinklr Inc (CXM) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CXM revenue for 2026-07-31 was $433.2M. Net income was $11.3M. Revenue was up 97.4% from 2026-04-30 to 2026-07-31. CXM currently screens at market cap $2.17B and trailing P/E 21.5.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CXM currently screens at market cap $2.17B and trailing P/E 21.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CXM and REGN stock pages for the full models.
Not investment advice.